Highlights of ASH in North America

Join global hematology leaders at Highlights of ASH in North America, a two-day program offered in multiple locations, to explore and discuss the most influential and novel research presented at the latest ASH annual meeting.

Highlights of ASH in North America

Button - Play 66th ASH Annual Meeting and Exposition

Register Today

Highlights of ASH in North America attendees will connect with top hematology experts in person and learn how to apply the latest research to their own areas of expertise. Choose the location that best meets your schedule.

Chicago, Illinois | January 9-10, 2026 
New York, New York | January 9-10, 2026
Washington, D.C. | January 16-17, 2026
Seattle, Washington | January 30-31, 2026

Registration is now open!

Register Now View Registration Information
About Highlights Of ASH
Meeting Information

Program Schedule
Acknowledgments

About Highlights of ASH

Nothing compares to in-person connection. ASH strives to create opportunities for researchers and clinicians to interact with peers while learning about important developments in science, patient care, and education. The Highlights of ASH series offers convenient, streamlined hematology events held in multiple locations. No matter your role, Highlights of ASH programs are designed to ensure all attendees leave feeling more confident and better equipped for career success.

View Registration Information 

HOA_Speaker
HOA_NA_Meeting

Cutting-edge Research from Across Disciplines

Hear the most influential and novel research in malignant and classical hematology shared at the latest ASH annual meeting.

 

Instant Insights

Ask questions and get feedback from top hematology experts in real time.

 

Real Advice You Can Use

Gain insight into local and regional standards of care. Discover how emerging technology can enhance your practice.

 

Meet Experts in Your Field

Network with colleagues of all career stages and form connections in your field.

 

Earn CME credits

Attendees can earn continuing medical education (CME) credits for physicians, while non-physicians and other health care professionals may receive a Certificate of Participation.

Meeting Information

HOA_NA_Attendees
Registration
To begin the online registration process for Highlights of ASH, you will need your ASH username and password. If you do not have an ASH account, you can create one when you begin the registration process. See Additional Registration Information
HOA_NA_Hotel_Info
Hotel Information
ASH has secured discounted hotel rooms at each Highlights of ASH meeting locations. Please note that each meeting ends late Saturday afternoon. To ensure your safe and comfortable travel, ASH has secured rooms at the discounted rate through Saturday night. View Hotel Information

HOA_NA_Host_Satellite_Symposia
Satellite Symposia
Satellite Symposia are industry-sponsored, CME-accredited symposia that are offered in conjunction with ASH specialty meetings. They are independently organized and address topics not found in the ASH schedule and program. View Satellite Symposia Information
HOA_CME_MOC
CME and MOC Information
The American Society of Hematology (ASH) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. View CME and MOC Information
HOA_Become_an_Exhibitor
Become an Exhibitor
Plan now to exhibit at the Highlights of ASH to build visibility, develop and nurture customer relationships, and introduce new products and services. Exhibit at Highlights of ASH

HOA_NA_Accessibility
Accessibility Resources
ASH is committed to an inclusive meeting for all, focusing on accessibility for participants with disabilities. We encourage the accessibility community to travel to ASH events confidently, knowing support and resources are available.View Accessibility Resources

Program Schedule

This program is curated for hematologists, oncologists, fellows and trainees, allied health professionals, advanced practice providers, and hematopathologists. The following session topics correspond to the 2026 Highlights of ASH in North America and are subject to change. The program schedule is identical for all 2026 Highlights of ASH North America locations.

11:00 a.m. Registration and Exhibits Open (Lunch provided)
11:45 p.m. Welcome and Introductions
12:00 p.m. Plasma Cell Disorder Personalization: How I Risk Stratify Patients and Sequence Therapies in Myeloma, AL Amyloidosis, and Their Precursors
Noura Elsedawy, MBBCh 
University of Tennessee Health Science Center 		New York, NY
Washington, DC
Craig Hofmeister, MD, MPH
Emory University  		 Seattle, WA 
Ruben Niesvizky, MD 
Weill Cornell Medicine  		 Chicago, IL 
12:45 p.m. Expanding Access, Enhancing Precision in Hematopoietic Cell Transplantation: Innovations in Graft-versus-Host Disease Prophylaxis, Measurable Residual Disease-Guided Strategies, and Post-Transplant Care 
Alexandra Gomez Arteaga, MD
Weill Cornell Medicine, New York Presbyterian Hospital 		 New York, NY 
Marcos de Lima, MD 
The Ohio State University  		 Seattle, WA
Mark Levis, MD, PhD 
Johns Hopkins University    		 Washington, DC  
Mariam Nawas, MD
University of Chicago Medical Center
 
 Chicago, IL 
1:30 p.m. Advances in Pediatric Hematologic Malignancies from Enhanced Risk Stratification to Novel Therapies
Rebecca Gardner, MD 
St. Jude Children’s Research Hospital 		Chicago, IL 
Rachel Rau, MD 
University of Washington 		 Seattle, WA
Rayne H. Rouce, MD 
Baylor College of Medicine  		 New York, NY 
Washington, DC 
2:15 p.m. Panel Discussion
2:45 p.m. Coffee Break and Exhibits Open
3:00 p.m. Advances in Aggressive Lymphoma in Novel Therapy Era
Manali Kamdar, MD, MBBS 
University of Colorado 		Seattle, WA
John Kuruvilla, MD, FRCPC 
Princess Margaret Cancer Centre  		 New York, NY 
Selay Lam, MD 
Western University, London Health Sciences Centre  		 Chicago, IL  
Craig Moskowitz, MD
University of Miami, Sylvester Comprehensive Cancer Center
 
 Washington, DC  
3:45 p.m. How I Treat Acute Lymphoblastic Leukemia in 2025: Sequencing for Cure in the Era of Targeted and Novel Immune Therapies

Emily Curran, MD 
University of Cincinnati Cancer Center 

 New York, NY 
Rawan Faramand, MD 
H. Lee Moffitt Cancer Center 		Washington, DC  
John Molina, MD, EdM 
Taussig Cancer Institute, Cleveland Clinic 		Seattle, WA
Lori Muffly, MD, MS 
Stanford University  		 Chicago, IL  
4:30 p.m. Updates in Management of Indolent Lymphoma and Chronic Lymphocytic Leukemia
Jia Ruan, MD, PhD
Weill Cornell Medicine 		 New York, NY 
Mazyar Shadman, MD, MPH 
Fred Hutchinson Cancer Center, University of Washington 		Chicago, IL 
Seattle, WA
Tanya Siddiqi, MD 
City of Hope Orange County		 Washington, DC 
5:15 p.m. Panel Discussion
5:45 p.m.  Highlights of ASH Day 1 Program Adjournment 
7:00 a.m. Registration and Exhibits Open
(Breakfast provided)
7:45 a.m. Welcome and Introductions
8:00 a.m.

Emerging Frontiers in Bleeding Disorder Care: Advances in Therapies and Clinical Practice

Tyler W. Buckner, MD, MSc
University of Colorado School of Medicine

Washington, DC
Peter H. Cygan, MD
Penn State Health Milton S. Hershey Medical Center		 New York, NY
Kristina Maria Haley, DO
Oregon Health & Science University		 Seattle, WA 
Lynn Malec, MD, MSc
Versiti Blood Research Institute, Medical College of Wisconsin 		 Chicago, IL 
8:45 a.m.

Turning the Tide in Thrombosis: Breakthrough Mechanisms, Diagnostics, and Therapies

Joana M. Mack, MD
Arkansas Children's Hospital, University of Arkansas for Medical Sciences

Washington, DC 
Anna L. Parks, MD
University of Utah		 Seattle, WA
Rachel P. Rosovsky, MD, MPH
Massachusetts General Hospital, Harvard Medical School		 New York, NY
Robert Stern, MD, EdM 
Brigham and Women’s Hospital 		 Chicago, IL 
9:30 a.m.

Hematology Through a Gender Lens: Evolving Insights into Unique and Underrecognized Challenges in Hematology
Imo J. Akpan, MD
Columbia University Irving Medical Center		 New York, NY 
Allison P. Wheeler, MD, MSCI
University of Washington		 Chicago, IL 
Seattle, WA
Meera Chitlur, MD
Central Michigan University, Children's Hospital of Michigan
 
 Washington, DC 
10:15 a.m. Panel Discussion 
10:45 a.m. Coffee Break and Exhibits Open
11:00 a.m.

Progress and Promise: Practice Insights into Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Chronic Myeloid Leukemia from the Amercian Society of Hematology 2025

Uma Borate, MD, MS
The Ohio State University

Chicago, IL
Akriti Gupta Jain, MD, FACP
Cleveland Clinic		 New York, NY
Seattle, WA

Brandi Reeves, MD
University of North Carolina at Chapel Hill

Washington, DC
11:45 a.m.

The Future is Now: Advances in Acute Myeloid Leukemia

Jessica K. Altman, MD
Northwestern Medicine

New York, NY
David Sanford, MD
UBC-BC Cancer Agency, Vancouver Coastal Health		 Seattle, WA 
Caner Saygin, MD
University of Chicago

Chicago, IL 

Eunice S. Wang, MD
Roswell Park Comprehensive Cancer Center

 Washington, DC 
12:30 p.m. Panel Discussion
1:00 p.m. Lunch with the Experts
(All Speakers and Attendees)
2:15 p.m. Updates in Hemoglobinopathy Evaluation and Management

Oyebimpe O. Adesina, MD, MS
University of California Davis School of Medicine

Seattle, WA

Payal Desai, MD
Levine Cancer Institute, Atrium Health, Wake Forest University

New York, NY
India Sisler, MD
Children’s Hospital of Richmond at VCU		 Washington, DC
Madhav Vissa, MD
UCSF Benioff Children’s Hospital		 Chicago, IL
3:00 p.m.

Autoimmune Cytopenias: Targeted, Tailored, Transformed

Juliana P. Botero, MD, MS
Mayo Clinic

New York, NY
Cyrus C. Hsia, MD, FRCPC
Western University, London Health Sciences Center		 Washington, DC

Caroline Piatek, MD
University of Southern California

Seattle, WA
Senthil Sukumar, MD, MS
Baylor College of Medicine		 Chicago, IL
3:45 p.m.

Artificial Intelligence & Informatics in Hematology: Driving Practice Improvement and Patient-Centered Care

Benjamin Chin-Yee, MD, MA, FRCPC
Western University

Chicago, IL

Barbara Lam, MD
Fred Hutchinson Cancer Center, University of Washington

Seattle, WA
Ang Li, MD, MS
Baylor College of Medicine

New York, NY
Rushad Patell, MD
Beth Isreal Deaconess Medical Center		 Washington, DC
4:30 p.m. Panel Discussion
5:00 p.m. Closing Remarks and Adjournment

Acknowledgments

Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, our State Society Partners, and our company partners for providing educational grants in support of the 2026 Highlights of ASH in North America.

Highlights of ASH Steering Subcommittee

  • Jia Ruan, MD, PhD, Chair, Weill Cornell Medicine 
  • Tyler Buckner, MD, MSc, University of Colorado Denver 
  • Payal C. Desai, MD, Atrium Health
  • Cyrus C. Hsia, MD, BSc, FRCPC, Western University
  • Manali Kamdar, MD, University of Colorado
  • Ang Li, MD, MS, Baylor College of Medicine
  • John C. Molina, MD, MEd, Cleveland Clinic
  • Ruben Niesvizky, MD, Weill Cornell Medicine
  • Rachel P. Rosovsky, MD, Harvard Medical School
  • Rayne H. Rouce, MD, Baylor College of Medicine
  • Eric Tse, MBBS, PhD, Hong Kong University

State Societies

We also wish to recognize the commitment of our State Societies in their support of the Highlights of ASH in North America meeting.

Gasco Logo Wide

Corporate Support

  • AstraZeneca
  • Novartis Pharmaceuticals Corporation